Journal of Clinical Oncology, ISSN 0732-183X, 06/2019, Volume 37, Issue 17, pp. 1516 - 1517
Journal Article
The New England journal of medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 14, pp. 1358 - 1359
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 17, pp. 1672 - 1673
To the Editor: The results of the Suppression of Ovarian Function Trial (SOFT) by Francis et al. (Jan. 29 issue) 1 are presented as practice changing. However,...
MEDICINE, GENERAL & INTERNAL | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Tamoxifen - therapeutic use | Female | Androstadienes - therapeutic use | Aromatase Inhibitors - therapeutic use | Breast Neoplasms - drug therapy | Chemotherapy | Breast cancer | Invasiveness | Tumors
MEDICINE, GENERAL & INTERNAL | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Tamoxifen - therapeutic use | Female | Androstadienes - therapeutic use | Aromatase Inhibitors - therapeutic use | Breast Neoplasms - drug therapy | Chemotherapy | Breast cancer | Invasiveness | Tumors
Journal Article
Cancer, ISSN 0008-543X, 07/2019, Volume 125, Issue 13, pp. 2194 - 2202
Background Inflammatory breast cancer (IBC) is an uncommon and aggressive subtype of breast cancer associated with early disease recurrence and short survival....
BRCA | inflammatory breast cancer | mutations | germline | pathogenic | variants | DNA repair | BRCA2 protein | BRCA1 protein | Genes | Estrogens | Breast cancer | Inflammation | Genetic diversity | Carcinogenesis | ErbB-2 protein | Genetic screening | Metastases | Carcinogens | Epidermal growth factor | Testing laboratories | Womens health | Breast | Mutation | Progesterone | Growth factors
BRCA | inflammatory breast cancer | mutations | germline | pathogenic | variants | DNA repair | BRCA2 protein | BRCA1 protein | Genes | Estrogens | Breast cancer | Inflammation | Genetic diversity | Carcinogenesis | ErbB-2 protein | Genetic screening | Metastases | Carcinogens | Epidermal growth factor | Testing laboratories | Womens health | Breast | Mutation | Progesterone | Growth factors
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 02/2018, Volume 36, Issue 5, pp. 515 - 516
Journal Article
NEW ENGLAND JOURNAL OF MEDICINE, ISSN 0028-4793, 10/2014, Volume 371, Issue 14, pp. 1358 - 1358
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2018, Volume 115, Issue 45, p. E10712
The gut metabolic landscape is complex and is influenced by the microbiota, host physiology, and enteric pathogens. Pathogens have to exquisitely monitor the...
Pathogens | Digestive system | Serine | Virulence | Anaerobic conditions | Variations | Biogeography | Amino acids | Gastrointestinal tract | Infections | Metabolism | Gene expression | Fatty acids | Microbiota | E coli | Pathways | Gastrointestinal system | Metabolic pathways | Digestive tract | Colonization | Citrobacter
Pathogens | Digestive system | Serine | Virulence | Anaerobic conditions | Variations | Biogeography | Amino acids | Gastrointestinal tract | Infections | Metabolism | Gene expression | Fatty acids | Microbiota | E coli | Pathways | Gastrointestinal system | Metabolic pathways | Digestive tract | Colonization | Citrobacter
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 4566 - 4566
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2018, Volume 379, Issue 17, pp. 1683 - 1685
To the Editor: The results of the Suppression of Ovarian Function Trial (SOFT) and the Tamoxifen and Exemestane Trial (TEXT) reported by Francis et al. (July...
MEDICINE, GENERAL & INTERNAL | SURGICAL OOPHORECTOMY | TAMOXIFEN | Low income groups | Aromatase | Pituitary (anterior) | Gonadotropins | Breast cancer | Gonadotropin-releasing hormone | Tamoxifen | Health risk assessment
MEDICINE, GENERAL & INTERNAL | SURGICAL OOPHORECTOMY | TAMOXIFEN | Low income groups | Aromatase | Pituitary (anterior) | Gonadotropins | Breast cancer | Gonadotropin-releasing hormone | Tamoxifen | Health risk assessment
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2019, Volume 37, Issue 35, pp. 3350 - 3358
PURPOSE Outcome measures that comprehensively capture attributes of immuno-oncology agents, including prolonged treatment-free time and persistent...
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 04/2019, Volume 37, Issue 11, pp. 862 - 862
OVARIAN SUPPRESSION | BENEFIT | IMPACT | EFFICACY | ONCOLOGY | ENDOCRINE THERAPY | TEXT | EXPRESSION | CHEMOTHERAPY
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 04/2015, Volume 372, Issue 17, p. 1673
Journal Article
Urology, ISSN 0090-4295, 05/2019, Volume 127, pp. 53 - 60
To test the validity of an Internet-based version of Expanded Prostate Cancer Index Composite (EPIC-26) versus the phone-based version. Most men will survive...
SATISFACTION | PAPER-AND-PENCIL | MEN | VERSION | UROLOGY & NEPHROLOGY | REPORTED OUTCOME MEASURES | RELIABILITY | CARE | Prostatic Neoplasms - pathology | Prospective Studies | Age Factors | Risk Assessment | Sickness Impact Profile | Neoplasm Invasiveness | Telephone - statistics & numerical data | Humans | Middle Aged | Internet - statistics & numerical data | Male | Prostatic Neoplasms - psychology | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Survival Analysis | Quality of Life | Aged | Neoplasm Staging | Longitudinal Studies | Cohort Studies | Urinary incontinence | Medical research | Care and treatment | Analysis | Medicine, Experimental | Internet | Prostate cancer | Sexual disorders | Cancer
SATISFACTION | PAPER-AND-PENCIL | MEN | VERSION | UROLOGY & NEPHROLOGY | REPORTED OUTCOME MEASURES | RELIABILITY | CARE | Prostatic Neoplasms - pathology | Prospective Studies | Age Factors | Risk Assessment | Sickness Impact Profile | Neoplasm Invasiveness | Telephone - statistics & numerical data | Humans | Middle Aged | Internet - statistics & numerical data | Male | Prostatic Neoplasms - psychology | Prostatic Neoplasms - mortality | Prostatic Neoplasms - therapy | Survival Analysis | Quality of Life | Aged | Neoplasm Staging | Longitudinal Studies | Cohort Studies | Urinary incontinence | Medical research | Care and treatment | Analysis | Medicine, Experimental | Internet | Prostate cancer | Sexual disorders | Cancer
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 10/2019, p. JCO.18.01967
PURPOSE The Tamoxifen and Exemestane Trial (TEXT)/Suppression of Ovarian Function Trial (SOFT) showed superior outcomes for premenopausal women with hormone...
Journal Article
Cancer Research, ISSN 0008-5472, 07/2018, Volume 78, Issue 13 Supplement, pp. 4207 - 4207
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 10/2014, Volume 371, Issue 14, pp. 1357 - 1359
To the Editor: In a planned subgroup analysis of the Tamoxifen and Exemestane Trial (TEXT) and the Suppression of Ovarian Function Trial (SOFT) reported by...
WOMEN | MEDICINE, GENERAL & INTERNAL | TAMOXIFEN | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Tamoxifen - therapeutic use | Female | Androstadienes - therapeutic use | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy | Epidermal growth factor | Aromatase | Breast cancer | Tamoxifen | Health risk assessment | ErbB-2 protein | Tumors
WOMEN | MEDICINE, GENERAL & INTERNAL | TAMOXIFEN | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Tamoxifen - therapeutic use | Female | Androstadienes - therapeutic use | Triptorelin Pamoate - therapeutic use | Breast Neoplasms - drug therapy | Epidermal growth factor | Aromatase | Breast cancer | Tamoxifen | Health risk assessment | ErbB-2 protein | Tumors
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 9550 - 9550
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. 538 - 538
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 12/2016, Volume 34, Issue 34, pp. 4189 - 4190
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2018, Volume 36, Issue 15_suppl, pp. 9531 - 9531
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.